
Dana Marie Roque MD
Gynecologic Oncology
Associate Professor, Gynecologic Oncology, University of Maryland-Greenebaum Cancer Center; Director, Center of Excellence in Minimally Invasive Gynecology
22 S Greene StBaltimore, MD 21201
Fax+1 410-328-8389
Overview of Dr. Roque
Dr. Dana Roque is an obstetrician/gynecologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center, University of Maryland Baltimore Washington Medical Center, University of Maryland Upper Chesapeake Medical Center, University of Maryland Medical Center Midtown Campus, and Veterans Affairs Maryland Health Care System-Baltimore Division. She received her medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 19 years. Dr. Roque accepts several types of health insurance, listed below. She is one of 121 doctors at University of Maryland Medical Center and one of 125 doctors at University of Maryland Baltimore Washington Medical Center who specialize in Obstetrics & Gynecology. She has more than 60 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2011 - 2014
UPMC Medical EducationResidency, Obstetrics and Gynecology, 2007 - 2011
University of North Carolina at Chapel Hill School of MedicineClass of 2007
Certifications & Licensure
MD State Medical License 2014 - 2027
CT State Medical License 2011 - 2015
PA State Medical License 2007 - 2012
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab Start of enrollment: 2017 Apr 03
Publications & Presentations
PubMed
- A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.Alessandro D Santin, Dana M Roque, Eric R Siegel, Victoria M Ettorre, Michelle Greenman
Clinical Cancer Research. 2026-08-03 - 1 citationsComparing Acute Toxicity of Proton and Photon Radiation Therapy in Newly Diagnosed Gynecologic Primaries.Matthew H Brown, Ariel E Pollock, Kai Sun, Kimberly Marter, David Alicia
International Journal of Radiation Oncology, Biology, Physics. 2026-03-15 - Inhibition of P-glycoprotein using photoimmunotherapy in peritoneal metastasis mouse model.Kaitlyn A Moore, Brian Schnoor, Kathryn L McNaughton, Idrisa Rahman, Benjamin D Powers
Photochemistry and Photobiology. 2026-03-02
Press Mentions
New Study Reveals a Two-Drug Combination to Fight Malignant Ovarian CancerFebruary 15th, 2022
Yale Cancer Center Led Research Shows New Drug Combination Effective for Patients with Advanced Ovarian CancerFebruary 14th, 2022
Combo Tx Active in Recurrent, Platinum-Resistant Ovarian CancerMarch 26th, 2021
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Wyoming BlueChoice Personal
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Connecticare FlexPOS
Health Net Oregon PPO
Humana ChoiceCare Network PPOMultiplan PHCS PPO
Multiplan PPO
ODS Network
Oxford Health Freedom
Oxford Health Liberty
PacificSource Preferred PSN
Providence Health System Personal Option
Providence Health System Preferred PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









